Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as "a Kafkaesque nightmare" with over-officious bureaucracy putting pointless hurdles in patients' way
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.